24TimeNews Cover a wide range of topics from politics and business to entertainment and sports and news stories.
More than one in four people with Type 2 diabetes use GLP-1 receptor agonists, a class of widely prescribed medications. However, new research from Stanford Medicine and international collaborators suggests…
GLP-1 medications, such as semaglutide (Ozempic, Wegovy, and Rybelsus), commonly prescribed for diabetes and obesity may also be linked to better mental health outcomes, according to new research. The study…
Three recently released Cochrane reviews conclude that GLP-1 medications, such as Ozempic, can lead to meaningful weight loss. However, the findings also highlight concerns about the heavy involvement of drug…
Experts from UCL and the University of Cambridge warn that many people prescribed newer weight loss medications may not be receiving enough nutrition guidance to support safe, long-term weight loss.…
A new real-world comparison finds that bariatric surgery leads to dramatically more weight loss than popular injectable medications. After two years, people who underwent sleeve gastrectomy or gastric bypass lost…
A new study led by a researcher at University College London (UCL) has found that the anti-obesity medication semaglutide (Ozempic and Wegovy) may help prevent heart attacks and other major…
A promising group of medications already used to treat diabetes and obesity may also hold potential for tackling alcohol and drug addiction, according to a new study published in the…
A major study from Cleveland Clinic found that people with both obesity and type 2 diabetes who had weight-loss surgery lived longer and experienced fewer serious health issues than those…
New research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (September 15-19) shows that some individuals who are taking…
Weight loss drugs like Ozempic and Wegovy are used by over 15 million adults in the U.S., or 4.5% of the population. Despite their effectiveness, they have drawbacks. Their effect…